Please login to the form below
NIH
This page shows the latest NIH news and features for those working in and with pharma, biotech and healthcare.
GSK, Vir’s sotrovimab cuts hospitalisation and death risk by 79% in COVID-19 outpatients
Meanwhile, the US National Institutes for Health (NIH) has updated its COVID-19 treatment guidelines to include sotrovimab as a treatment for non-hospitalised patients with mild-to-moderate COVID-19, ... According to GSK and Vir, the NIH has also noted
Latest news
-
US announces $3bn funding boost for antiviral COVID-19 treatments
Research and Development Authority (BARDA) and the National Institutes of Health (NIH). ... As part of this plan, the NIH will evaluate, prioritise and advance antiviral treatment candidates to phase 2 clinical trials.
-
AstraZeneca to supply US government with 500,000 additional doses of its COVID-19 antibody
NIH). In these studies, researchers are evaluating the safety and efficacy of the investigational LAAB combination for the treatment of individuals with COVID-19 in the outpatient and hospitalised settings, respectively.
-
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
The US National Institutes of Health (NIH) sponsored ACTIV-3 trial is evaluating VIR-7831 in hospitalised adults with COVID-19.
-
Moderna announces plans for COVID-19 variant-specific booster jabs and new production targets
NIH) for phase 1 testing.
-
NIH trial of AZ's long-acting COVID-19 antibody launches in the US
The ACTIV-3 study is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID), which is part of the US National Institutes of Health (NIH).
US announces $3bn funding boost for antiviral COVID-19 treatments
AstraZeneca to supply US government with 500,000 additional doses of its COVID-19 antibody
GSK, Vir halt enrolment of phase 3 COVID-19 antibody study
Moderna announces plans for COVID-19 variant-specific booster jabs and new production targets
More from news
Approximately 8 fully matching, plus 87 partially matching documents found.
Latest Intelligence
-
Developing a COVID-19 vaccine
The phase 1 study, which is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle, aims to recruit 45 healthy men
-
As COVID-19 takes over the world, biopharma fights back
Lane is currently overseeing ongoing studies at the US National Institutes of Health (NIH), including its remdesivir study.
-
Driving the innovation engine
key. Cultural adoption is another goal. NIH (Not Invented Here) Syndrome is a fact of life in organisations large and small.
-
Streamlining clinical trials – why better data use is key
Today, CTTI is building on this work by collaborating with an NIH workgroup to develop a comprehensive plan for assessing the NIH’s sIRB policy, and by developing resources to assist
-
SEO for the healthcare industry
Frequently, the leader for UK searches is www.NHS.uk/conditions while www.webmd.com, www.cdc.gov, www.mayoclinic.org and http://www.ncbi.nlm.nih.gov/ are big hitters
Developing a COVID-19 vaccine
As COVID-19 takes over the world, biopharma fights back
Driving the innovation engine
Streamlining clinical trials – why better data use is key
SEO for the healthcare industry
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Dan Carucci becomes global chief medical officer of McCann Health
He also chairs a scientific advisory group for the US National Institutes of Health (NIH) extramural programmes.
-
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences
Shailubhai has also previously served at Callisto Pharmaceuticals, Monsanto Company and as a senior staff fellow at the National Institutes of Health (NIH).
-
Sanofi names CSO Gary Nabel to Ebola role
Elias Zerhouni, president of Sanofi global research and development, said: “Given his past experience in public health epidemics as director of the NIH vaccine research centre and his leadership in developing ... an Ebola vaccine at NIH, Dr Nabel is
-
Former Pfizer exec Stephen Williams joins Venaxis board
run by the Foundation for NIH from 2005-2007.
-
Eric Green named NIH's data science lead
NIH). Dr Green takes the role on an interim basis while the NIH attempts to find someone to take on the position on a permanent basis to lead its efforts to ... Dr Green has been director of the NHGRI since 2009, having previously served as scientific
Dan Carucci becomes global chief medical officer of McCann Health
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences
Sanofi names CSO Gary Nabel to Ebola role
Former Pfizer exec Stephen Williams joins Venaxis board
Eric Green named NIH's data science lead
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
2021; 172:314-338. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816567/ Accessed June 2, 2021. 17. Byrne J. Key learnings from COVID-19 vaccine development: Power of cross industry
-
Remote Patient Monitoring
The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM). With the onset of lockdown, and a sense of unease when visiting conventional clinical settings,
-
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
The effects of this guidance have been shown in this five-year progress report released last year, alongside other policies and ongoing efforts by the NIH. ... the 1993 NIH Revitalisation Act), we are seeing how effective such policies can be.
-
WHITE PAPER: What's missing in women's health?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139599/pdf/fnins-08-00256.pdf. Published August 21, 2014. Accessed May 4, 2020. 18. Hinde N. ... Jama. 2009; 288(3):321–333. http://www.ncbi.nlm.nih.gov/pubmed/12117397. Published 2009.Accessed February 27,
-
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
WHITE PAPER: What's missing in women's health?
More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
-
Events Executive
-
Depending on Experience
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Understanding the ‘real world’ starts and ends with the patient
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Sanofi raises profit forecast following positive Q2 results
- Biogen/Eisai push for second approval in Alzheimer’s disease
- Reducing primary care antibiotic use may not be enough to counter antimicrobial resistance
- SoftBank buys $5bn stake in Roche
- Live Webinar: Making Wearable Technology Scalable and Adoptable
- Live Webinar: Transforming the Future of Health & Aging from a Global Health & Social Impact Approach
- Investors respond positively to “strong” Eli Lilly results
No results were found
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- Ask the writers: Transitioning from academia to medical writing
- Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
- Strategic launch planning: familiar framework, new mindset
- By James Aird...
- Guide
- How to embrace behavioural science principles in healthcare MR...
